hers semaglutide injections Novo is suing Hims & to halt obesity drug copycats Novo Nordisk, Hims & Hers

NEWS / BLOG 2025.12.12 GLP-1 GLP-1GLP-1 GLP-1 GLP-1 1

Clinical trials showing the medications effectiveness typically ran for 68 weeks or longer

For anyone seriously considering GLP-1 therapy and wanting flexibility, real support, and a platform with a legitimate track record, Measured Health is worth a direct look

Lotfi, S

The outlook for the market remains positive, supported by rising health awareness, expanding reimbursement frameworks, and sustained technological advancement

Tirzepatide has emerging and strong cardiovascular data from the SUMMIT trial, which showed a 38% reduction in worsening heart failure events in patients with HFpEF and obesity